Research Interests
Cardiovascular Medicine and HaematologyProf Christina Bursill
Grant-Funded Research Professor
School of Medicine
College of Health
Eligible to supervise Masters and PhD as Principal Supervisor - email supervisor to discuss availability.
Prof Christina Bursill (BSc (Hons 1) PhD, Adelaide University; Postdoc, Oxford University, UK) is a leader in cardiovascular biology for her expertise in the biology and mechanisms of atherosclerotic plaques, the fatty deposits in the blood vessels of the heart that cause heart attacks. Prof Bursill also has expertise in the mechanisms of angiogenesis, the process of new blood vessel formation that is critical for tissue repair following a heart attack and also for wound healing that is impaired in diabetes.She is Director of the Vascular Research Centre at the South Australian Health and Medical Research Institute (SAHMRI) and Adelaide University and has held two National Heart Foundation (NHF) Fellowships. As CIA she has received >$5.7 million in competitive national research funding in the last 5 years. Prof Bursill has published >120 manuscripts, supervised >18 PhD students to completion and currently leads a research team of ten people.Prof Bursill is Chair the South Australian Cardiovascular Research network which seeks to bring together cardiovascular researchers from across South Australia to foster collaboration and drive research excellence and advocacy. She is currently a Board member of the International Atherosclerosis Society and has held positions in the leading cardiovascular bodies nationally including an elected board member (Treasurer) for the Australian Cardiovascular Alliance (ACvA) and is past-President of the Australian Atherosclerosis Society.
Our group is interested in investigating new mechanisms and targets that underlie the development of fatty deposits in the arteries of the heart, a process called atherosclerosis, that causes heart attacks. We also undertake research looking at the regulation of new blood vessel formation (angiogenesis), which can determine how well a heart attack patient recovers. We have a host on pathophysiologically relevant in vitro and in vivo models established in our laboratory.
Project 1
Title: The effect of fenofibrate on wound healing
Description: Human trials have found that the risk of amputation following a foot ulcer is reduced with fenofibrate (Vitamin B) supplementation. In vitro and in vivo studies have also shown that angiogenesis is increased with the addition of fenofibrate. This study will determine if topically applied fenofibrate increases would healing in an in vivo model established in our laboratory.
Project available for: Honours
Location: SAHMRI
Research project start: Semester 1
Project 2
Title: The role of the glycoprotein receptor ASGR1 in unstable atherosclerosis
Description: A GWAS study has identified that a mutation in ASGR1 reduces the risk of a cardiovascular event by 34%. The mechanisms for this are poorly understood and will be investigated using in vitro and in vivo models in this project.
Project available for: Honours
Location: SAHMRI
Research project start: Semester 1
| Date | Position | Institution name |
|---|---|---|
| 2017 - ongoing | Heart Foundation Lin Huddleston Senior Research Fellow | University of Adelaide |
| 2017 - ongoing | Senior Research Fellow | The University of Adelaide |
| Language | Competency |
|---|---|
| English | Can read, write, speak, understand spoken and peer review |
| Date | Institution name | Country | Title |
|---|---|---|---|
| The University of Adelaide | Australia | BSc | |
| The University of Adelaide | Australia | Hons 1 | |
| University of Adelaide, Adelaide | Australia | PhD |
| Date | Title | Institution | Country |
|---|---|---|---|
| 2017 | Director, Vascular Research Centre | South Australian Health and Medical Research Institute, Adelaide | Australia |
| 2010 - 2016 | Leader Immunobiology Group | The Heart Research Institute, Newtown | Australia |
| 2007 - 2010 | Senior Research Officer | The Heart Research Institute, Newtown | Australia |
| 2001 - 2006 | Postdoctoral Fellow | University of Oxford, Oxford | United Kingdom |
| Year | Citation |
|---|---|
| 2026 | Nankivell, V., Liu, J., Stretton, L., Tan, J. T. M., Psaltis, P. J., & Bursill, C. A. (2026). Vascular Biology of Smooth Muscle Cells and Arterial Restenosis. In Mechanisms of Vascular Disease A Textbook for Vascular Specialists (pp. 159-185). Springer Nature Switzerland. DOI |
| 2026 | Wong, N. K. P., Solly, E. L., Bursill, C. A., Ng, M. K. C., & Tan, J. T. M. (2026). Pathophysiology of Angiogenesis and Its Role in Vascular Disease. In Mechanisms of Vascular Disease A Textbook for Vascular Specialists (pp. 125-158). Springer Nature Switzerland. DOI |
| 2020 | Nankivell, V., Primer, K., Vidanapathirana, A., Psaltis, P., & Bursill, C. (2020). Vascular Biology of Smooth Muscle Cells and Restenosis. In R. Fitridge (Ed.), Mechanisms of Vascular Disease A Textbook for Vascular Specialists (3rd ed., pp. 117-139). Cham, Switzerland: Springer. Scopus7 |
| 2020 | Wong, N. K. P., Solly, E. L., Bursill, C. A., Tan, J. T. M., & Ng, M. K. C. (2020). Pathophysiology of Angiogenesis and Its Role in Vascular Disease. In N. K. P. Wong (Ed.), Mechanisms of Vascular Disease (pp. 89-116). Springer International Publishing. DOI Scopus9 |
| 2020 | Fernando, S., Bursill, C. A., Nicholls, S. J., & Psaltis, P. J. (2020). Pathophysiology of Atherosclerosis. In Mechanisms of Vascular Disease A Textbook for Vascular Specialists Third Edition (pp. 19-45). Springer International Publishing. DOI Scopus7 |
| 2017 | Lam, Y. T., Lecce, L., Bursill, C. A., & Ng, M. K. C. (2017). The Role of Sex Steroids in Angiogenesis. In J. L. Mehta, P. Mathur, & N. S. Dhalla (Eds.), Advances in Biochemistry in Health and Disease (Vol. 6, pp. 445-471). SPRINGER. DOI Scopus4 WoS4 |
| Year | Citation |
|---|---|
| 2025 | Cartland, S., Kelland, E., Le, N., Stanley, C., Menezes, R., Murphy, M., . . . Kavurma, M. (2025). Females exhibit greater mitochondrial endothelial dysfunction, impairing vascular healing in diabetes-associated peripheral artery disease.. In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY Vol. 45 (pp. 2 pages). MD, Baltimore: LIPPINCOTT WILLIAMS & WILKINS. DOI |
| 2025 | Cartland, S., Kelland, E., Le, N., Stanley, C., Menezes, R., Murphy, M., . . . Kavurma, M. (2025). Females exhibit greater mitochondrial endothelial dysfunction, impairing vascular healing in diabetes-associated peripheral artery disease. In ATHEROSCLEROSIS Vol. 407 (pp. 2 pages). SCOTLAND, Glasgow: ELSEVIER IRELAND LTD. |
| 2024 | Solly, E. L., Bouman Chen, Z., Luo, Y., Mulangala, J., Di Bartolo, B. A., Nicholls, S. J., . . . Tan, J. T. M. (2024). Inhibition of microRNA-181c-5p rescues diabetes-impaired angiogenesis through activation of key mediators of angiogenesis, cell survival and novel genes, elmo3 and trib1. In EUROPEAN HEART JOURNAL Vol. 45 (pp. 1 page). ENGLAND, London: OXFORD UNIV PRESS. DOI WoS1 |
| 2024 | Bursill, C., Pullen, B. J., Debebe, D., Sandeman, L., Wattchow, N. E., Vidanapathirana, A., . . . Packer, N. H. (2024). Deletion of the asialyloglycoprotein receptor-1 (ASGR1) causes atheroprotective effects in vitro and in vivo. In Abstracts of the European Society of Cardiology Congress (ESC, 2024) as published in European Heart Journal Vol. 45 (pp. ehae6663875-1). London, England and Virtual Online: Oxford University Press. DOI |
| 2023 | Liyanage, S., Williamson, A., Salagaras, T., Hassanshahi, M., Long, A., Tran, D., . . . Psaltis, P. (2023). Inhibitory And Metabolic Effects Of Diabetes On Yolk Sacderived Endothelial-macrophage Progenitors In Postnatal Murine Tissues. In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY Vol. 43 (pp. 2 pages). PA, Philadelphia: LIPPINCOTT WILLIAMS & WILKINS. DOI |
| 2022 | Solly, E. L., Mulangala, J., Di Bartolo, B. A., Nicholls, S. J., Psaltis, P. J., Bursill, C. A., & Tan, J. T. M. (2022). Inhibition of microRNA-181c rescues diabetes-impaired angiogenesis through activation of key angiogenesis mediators. In DIABETOLOGIA Vol. 65 (pp. S25-S26). Stockholm, SWEDEN: SPRINGER. |
| 2022 | Primer, K. R., Tan, J. T., Psaltis, P. J., & Bursill, C. A. (2022). Pyruvate Dehydrogenase Kinase 4 is a Novel Regulator of Endothelial Cell Mitochondrial Respiration in Diabetes-Impaired Angiogenesis: Implications for Preventing Diabetic Vascular Complications. In CIRCULATION Vol. 146 (pp. A10357). IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS. DOI |
| 2022 | Pullen, B. J., Vidanapathirana, A. K., Sandeman, L., Everest-Dass, A., Kolarich, D., Tan, J. T., . . . Bursill, C. A. (2022). Deletion of the Asialyloglycoprotein Receptor-1 Causes Athero-Protective Effects <i>in vitro</i> and <i>in vivo</i>. In CIRCULATION Vol. 146 (pp. A13417). IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS. DOI |
| 2022 | Lotfollahi, Z., Tan, J. T., Dawson, J., Fitridge, R., & Bursill, C. A. (2022). Tracking High-Density Lipoprotein Functionality in Diabetic and Non-Diabetic Patients With Toe Amputations. In CIRCULATION Vol. 146 (pp. A11756). IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS. DOI |
| 2020 | Gentile, C., Kesteven, S., Wu, J., Davies, M. J., Bursill, C., Feneley, M., & Figtree, G. (2020). Endothelial nitric oxide synthase plays a protective role in endothelial cells and cardiomyocytes against myocardial infarction. In JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY Vol. 140 (pp. 31). Beijing, PEOPLES R CHINA: ELSEVIER SCI LTD. DOI |
| 2020 | Cannizzo, C., Solly, E., Olaya, L. F., Abdollahi, M., Sutanto, S. S., Twigg, S. M., . . . Mclennan, S. (2020). Inhibition of miRNA-200b Rescues Diabetes-Impaired Angiogenesis. In DIABETES Vol. 69 (pp. 2 pages). ELECTR NETWORK: AMER DIABETES ASSOC. DOI |
| 2019 | Pisaniello, A. D., King, P., Di Bartolo, B. A., Liu, G., Gibson, R. A., Tan, J. T. M., . . . Nicholls, S. (2019). IMPACT OF FISH OIL SUPPLEMENTATION ON ACUTE VASCULAR INFLAMMATION IN HEALTHY VOLUNTEERS. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 73 (pp. 2091). New Orleans, LA: ELSEVIER SCIENCE INC. DOI |
| 2019 | Gentile, C., Kesteven, S., Wu, J., Bursill, C., Davies, M. J., & Figtree, G. (2019). A Novel Cellular and Genetic Approach to Investigate the Cardioprotective Role Played by Endothelial Nitric Oxide Synthase in Myocardial Infarction. In CIRCULATION RESEARCH Vol. 125 (pp. 2 pages). Boston, MA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2019 | Khalid, A., Abraham, A. N., Bai, D., Jadhav, A., Linklater, D., Nguyen, D., . . . Gibson, B. (2019). Electrospun diamond-silk membranes for biosensing applications. In Proceedings of SPIE - The International Society for Optical Engineering Vol. 11202 (pp. 1-5). online: SPIE. DOI Scopus1 WoS1 |
| 2019 | Morrison, K. R., Bursill, C., Solly, E., Shemesh, T., Nicholls, S., Brown, A. D., & Tan, J. T. M. (2019). HDL miR-181c as a Novel Biomarker for Diabetic Vascular Complications in Australian Aboriginal People. In DIABETES Vol. 68 (pp. 2 pages). CA, San Francisco: AMER DIABETES ASSOC. DOI WoS1 |
| 2018 | Gentile, C., Kesteven, S., Wu, J., Bursill, C., Davies, M., Feneley, M., & Figtree, G. (2018). Endothelial nitric oxide synthase plays a protective role against myocardial infarction. In FREE RADICAL BIOLOGY AND MEDICINE Vol. 128 (pp. S26). Chicago, IL: ELSEVIER SCIENCE INC. DOI WoS2 |
| 2018 | Akers, E. J., Mulangala, J., Psaltis, P. J., Bursill, C., Nicholls, S. J., & Di Bartolo, B. A. (2018). Lipoproteins and their Modified Forms Regulate Smooth Muscle Cell Calcification. In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY Vol. 38 (pp. 2 pages). CA, San Francisco: LIPPINCOTT WILLIAMS & WILKINS. DOI |
| 2018 | Mulangala, J., Akers, E. J., Solly, E. L., Psaltis, P. J., Tan, J. T., Nicholls, S. J., . . . Di Bartolo, B. A. (2018). Elevated Calcium Drives Inflammatory-Driven Angiogenesis. In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY Vol. 38 (pp. 2 pages). CA, San Francisco: LIPPINCOTT WILLIAMS & WILKINS. DOI |
| 2017 | Cannizzo, C. M., Adonopulos, A. A., Ridiandries, A., Vanags, L. Z., Yuen, S. C. G., Tsatralis, T., . . . Tan, J. T. (2017). VEGFR2 is Activated by High-Density Lipoproteins and Plays a Key Role in the Pro-Angiogenic Action of HDL in Ischemia. In CIRCULATION Vol. 136 (pp. 1 page). Anaheim, CA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2017 | Hourigan, S. T., Ridiandries, A., Tepper, E. R., Zhang, J. Q., Henriquez, R., Tsatralis, T., . . . Tan, J. T. (2017). The Regulation of miRNAs in rHDL-Induced Rescue of Diabetes-Impaired Angiogenesis. In CIRCULATION Vol. 136 (pp. 1 page). Anaheim, CA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2017 | Van Der Vorst, E., Theodorou, K., Wu, Y., Hoeksema, M., Goossens, P., Bursill, C., . . . Donners, M. (2017). HIGH DENSITY LIPOPROTEINS EXERT PRO-INFLAMMATORY EFFECTS ON MACROPHAGES VIA PASSIVE CHOLESTEROL DEPLETION AND PKC-NF-KB/STAT1-IRF1 SIGNALING. In ATHEROSCLEROSIS Vol. 263 (pp. E6). Prague, CZECH REPUBLIC: ELSEVIER IRELAND LTD. DOI WoS1 |
| 2015 | Robertson, S., Payet, C., Martinez, G. J., Barraclough, J., Celermajer, D., Bursill, C., & Patel, S. (2015). Colchicine Acutely Suppresses the NLRP3 Inflammasome in Acute Coronary Syndrome Patients Monocytes. In CIRCULATION Vol. 132 (pp. 2 pages). FL, Orlando: LIPPINCOTT WILLIAMS & WILKINS. WoS2 |
| 2015 | Yuan, J., Rajamani, K., King, E., Bursill, C., Lecce, L., Jenkins, A., . . . Ng, M. (2015). Fenofibrate Rescues Diabetes-related Impairment of Ischaemia-mediated Angiogenesis by PPARα Independent Modulation of Thioredoxin Interacting Protein. In DIABETES Vol. 64 (pp. A114). MA, Boston: AMER DIABETES ASSOC. |
| 2014 | Vanags, L., Tan, J., Wise, S., Ali, Z., & Bursill, C. (2014). ApoA-I Suppresses Neointimal Hyperplasia Following Stent Deployment and Modulates Neointimal Cellular Phenotype. In CIRCULATION Vol. 130 (pp. 2 pages). LIPPINCOTT WILLIAMS & WILKINS. |
| 2014 | Vanags, L. Z., Tan, J., Michael, J., Bilek, M., Wise, S., & Bursill, C. (2014). Immobilised apoA-I and High-Density Lipoproteins are Anti-Thrombotic and Exert Anti-Inflammatory Effects in Vascular Smooth Muscle Cells. In CIRCULATION Vol. 130 (pp. 2 pages). Chicago, IL: LIPPINCOTT WILLIAMS & WILKINS. |
| 2014 | Macer-Wright, J., Stanley, N., Tan, J., Bursill, C., & Hawkins, C. (2014). Chlorinated Nucleosides - Novel Mediators or Biomarkers of Disease?. In FREE RADICAL BIOLOGY AND MEDICINE Vol. 76 (pp. S45-S46). ELSEVIER SCIENCE INC. DOI |
| 2014 | Robertson, S., Dababneh, E., & Bursill, C. (2014). Aldosterone-Dependent Transfer of microRNA-Containing Exosomes Between Endothelial and Smooth Muscles Cells.. In HYPERTENSION Vol. 64 (pp. 2 pages). LIPPINCOTT WILLIAMS & WILKINS. WoS1 |
| 2014 | Ridiandries, A., Prosser, H., Hawkins, C., & Bursill, C. (2014). Broad-Spectrum Chemokine Inhibition Blocks Inflammation-Induced Pathological Angiogenesis but Preserves Hypoxia-Driven Physiological Angiogenesis. In ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY Vol. 34 (pp. 2 pages). LIPPINCOTT WILLIAMS & WILKINS. |
| 2013 | Macer-Wright, J., Stanley, N., Tan, J., Bursill, C., & Hawkins, C. (2013). Role of Chlorinated Nucleosides Produced by Hypochlorous Acid in the Perturbation of Cellular Function under Inflammatory Conditions. In FREE RADICAL BIOLOGY AND MEDICINE Vol. 65 (pp. S143). ELSEVIER SCIENCE INC. DOI |
| 2008 | Ali, Z. A., Bursill, C. A., Douglas, G., McNeill, E., Papaspyridonos, M., Tatham, A. L., . . . Channon, K. M. (2008). CCR2-mediated antiinflammatory effects of endothelial tetrahydrobiopterin inhibit vascular injury-induced accelerated atherosclerosis.. In Circulation Vol. 118 (pp. S71-S77). Orlando, FL: LIPPINCOTT WILLIAMS & WILKINS. DOI Scopus31 WoS30 Europe PMC24 |
| 2007 | Ali, Z. A., Bursill, C. A., Papaspyridonos, M., Akhtar, A. A., Greaves, D. R., Alp, N. J., & Channon, K. M. (2007). Tetrahydrobiopterin-dependent eNOS coupling attenuates vein graft atherosclerosis through inhibition of MCP-1 mediated monocyte recruitment to sites of vascular injury. In CIRCULATION Vol. 116 (pp. 445-446). LIPPINCOTT WILLIAMS & WILKINS. |
| 2007 | Ali, Z. A., Alkhtar, A. M., Bursill, C. A., Chouchury, R. R., Greaves, D. R., & Channon, K. M. (2007). Broad spectrum adenoviral CC-chemokine blockade attenuates long term vein graft accelerated atherosclerosis in ApoE-knockout mice. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY Vol. 49 (pp. 220A). LA, New Orleans: ELSEVIER SCIENCE INC. |
| 2006 | McAteer, M. A., Schneider, J. E., Ali, Z. A., Warrick, N., Bursill, C. A., von zur Muehlen, C., . . . Choudhury, R. P. (2006). Dual targeted microparticles of iron oxide detect endothelial adhesion molecule expression in mouse atherosclerosis by magnetic resonance imaging. In CIRCULATION Vol. 114 (pp. 337). IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS. |
| 2006 | Ali, Z. A., Papaspyridonos, M., Bursill, C. A., Tatham, A. L., deBono, J. P., Bendall, J. K., . . . Channon, K. M. (2006). Increased eNOS coupling protects against vein graft accelerated atherosclerosis in ApoE-KO mice. In CIRCULATION Vol. 114 (pp. 361). IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS. |
| 2006 | Bendall, J. K., Adlam, D., Bursill, C. A., de Bono, J., Tatham, A. L., Rinze, R., & Channon, K. M. (2006). Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II: Studies in endothelial-targeted Nox2 transgenic mice. In CIRCULATION Vol. 114 (pp. 117). IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS. |
| Year | Citation |
|---|---|
| 2024 | Nankivell, V., Sandeman, L., Stretton, L., Vidanapathirana, A. K., Rajora, M. A., Chen, J., . . . Bursill, C. A. (2024). Biomimetic porphyrin-lipid nanoparticles - novel nanoscale theranostics for multimodal imaging and therapy in atherosclerotic cardiovascular disease. Poster session presented at the meeting of Abstracts of the European Society of Cardiologists ESC Congress 2024, as published in European Heart Journal. London, UK: Oxford University Press. DOI WoS1 |
| 2022 | Primer, K. R., Tan, J. T., Psaltis, P. J., & Bursill, C. A. (2022). Pyruvate Dehydrogenase Kinase 4 is a Novel Regulator of Endothelial Cell Mitochondrial Respiration in Diabetes-Impaired Angiogenesis: Implications for Preventing Diabetic Vascular Complications. Poster session presented at the meeting of CIRCULATION. IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS. |
| 2022 | Lotfollahi, Z., Tan, J. T., Dawson, J., Fitridge, R., & Bursill, C. A. (2022). Tracking High-Density Lipoprotein Functionality in Diabetic and Non-Diabetic Patients With Toe Amputations. Poster session presented at the meeting of CIRCULATION. IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS. |
| 2022 | Pullen, B. J., Vidanapathirana, A. K., Sandeman, L., Everest-Dass, A., Kolarich, D., Tan, J. T., . . . Bursill, C. A. (2022). Deletion of the Asialyloglycoprotein Receptor-1 Causes Athero-Protective Effects in vitro and in vivo. Poster session presented at the meeting of CIRCULATION. IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS. WoS2 |
| 2022 | Nankivell, V. A., Vidanapathirana, A., Rajora, M., Psaltis, P., Tan, J. T., Tieu, W., . . . Bursill, C. A. (2022). Theranostic Properties of Porphysome Nanoparticles in Atherosclerotic Cardiovascular Disease. Poster session presented at the meeting of Abstracts of the American Heart Association Scientific Sessions (AHA#22), as published in Circulation. Chicago, IL: Lippincott Williams & Wilkins. DOI WoS2 |
| 2019 | Akers, E. J., Mulangala, J., Wilsdon, L. A., Psaltis, P. J., Bursill, C. A., Nicholls, S. J., & Di Bartolo, B. A. (2019). Lipoproteins and Their Modified Forms Regulate Early Stage Vascular Smooth Muscle Cell Calcification. Poster session presented at the meeting of ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. Boston, MA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2019 | Solly, E., Hourigan, S. T., Mulangala, J., Psaltis, P. J., Di Bartolo, B., Martin, N., . . . Tan, J. T. M. (2019). Inhibition of miR-181c Rescues Diabetes-Impaired Angiogenesis. Poster session presented at the meeting of DIABETES. CA, San Francisco: AMER DIABETES ASSOC. DOI |
| 2019 | Williamson, A., Toledo, D. F., Schwarz, N., Fernando, S., Dimasi, C., Liyanage, S., . . . Psaltis, P. J. (2019). Postnatal mouse aorta contains yolk sac-derived haemangioblasts with myeloid and endothelial plasticity and vasculogenic capacity. Poster session presented at the meeting of European Heart Journal. Paris, France: Oxford University Press. |
| 2019 | Fernando, S., Schwarz, N., Sandeman, L., Skoumbourdis, T., Zareh, J., Williamson, A., . . . Psaltis, P. J. (2019). Eukaryotic Elongation Factor 2 Kinase Regulates Cholesterol Uptake by Macrophages via Cd36 Scavenger Receptor Expression. Poster session presented at the meeting of CIRCULATION. Philadelphia, PA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2019 | Wong, N. K., Solly, E., Nicholls, S., Psaltis, P., Ng, M. K., Bursill, C. A., & Tan, J. T. (2019). <i>TRIM2</i> an<i>d CREBRF</i> Are Novel Regulators of Angiogenic Functions in Human Coronary Artery Endothelial Cells. Poster session presented at the meeting of CIRCULATION. Philadelphia, PA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2018 | Takata, K., Duong, M., Honda, S., Sidharta, S. L., Kim, S. W., Shishikura, D., . . . Nicholls, S. J. (2018). Association of Apolipoprotein C-III Distribution With Cholesterol Efflux Capacity and Coronary Plaque Burden. Poster session presented at the meeting of CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS. |
| 2018 | Duong, M., Nankivell, V., Bursill, C. A., & Nicholls, S. J. (2018). Obesity Impairs Reverse Cholesterol Transport in Ob/Ob Mice.. Poster session presented at the meeting of CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS. |
| 2017 | Morton, J., Bao, S., Vanags, L., Tsatralis, T., Ridiandries, A., Siu, C. -W., . . . Bursill, C. (2017). Stage-specific Effects of Apolipoprotein (apo) A-I Raising in Atherosclerosis: ApoA-I Suppresses Plaque Size and Preserves High-density Lipoprotein Function in Apo E<SUP>-/-</SUP> Mice With Early Stage <i>But Not</i> Late-stage Disease. Poster session presented at the meeting of CIRCULATION. Anaheim, CA: LIPPINCOTT WILLIAMS & WILKINS. |
| 2016 | Tan, J. T., Hourigan, S. T., Zhang, J. Q., Wong, N. K., Tepper, E. R., Prosser, H. C., . . . Bursill, C. A. (2016). miRNA-181c and its putative target TRIM2 mediate the ability of high density lipoproteins to rescue diabetes-impaired angiogenesis. Poster session presented at the meeting of as published in Diabetes. New Orleans, LA: American Diabetes Association. |
| 2015 | Tan, J. T. M., Prosser, H. C. G., Dunn, L. L., Vanags, L. Z., Ridiandries, A., Tsatralis, T., . . . Bursill, C. A. (2015). High Density Lipoproteins Rescue Diabetes-Impaired Angiogenesis via Scavenger Receptor-BI and Restoration of VEGF and HIF-1 alpha Stability. Poster session presented at the meeting of DIABETES. Boston, MA: AMER DIABETES ASSOC. WoS1 |
| 2014 | Van der Vorst, E. P. C., Theodorou, K., Plat, J., Van Eck, M., Rye, K. A., Bursill, C. A., . . . Donners, M. M. P. C. (2014). High density lipoproteins exert pro-inflammatory effects on macrophages via IKK2-and NIK-independent NF-kB activation. Poster session presented at the meeting of CARDIOVASCULAR RESEARCH. Barcelona, SPAIN: OXFORD UNIV PRESS. DOI |
| 2013 | Prosser, H. C., Tan, J. T., Dunn, L. L., Patel, S., Vanags, L. Z., Monger, S., . . . Bursill, C. A. (2013). Multifunctional Regulation of Angiogenesis by High Density Lipoproteins. Poster session presented at the meeting of CIRCULATION. Dallas, TX: LIPPINCOTT WILLIAMS & WILKINS. |
| 2013 | Morton, J., Bao, S., Celermajer, D. S., Ng, M. K., & Bursill, C. A. (2013). Strikingly Different Atheroprotective Effects of Apolipoprotein A-I in Early-Stage Versus Late-Stage Atherosclerosis. Poster session presented at the meeting of CIRCULATION. Dallas, TX: LIPPINCOTT WILLIAMS & WILKINS. WoS1 |
| 2012 | Quigley, A. F., Summers, F. A., Barrett, T. J., Bursill, C. A., & Hawkins, C. L. (2012). A novel role of myeloperoxidase in the induction of endoplasmic reticulum (ER) stress. Poster session presented at the meeting of FREE RADICAL BIOLOGY AND MEDICINE. ELSEVIER SCIENCE INC. DOI |
| 2012 | Quigley, A. F., Summers, F. A., Barrett, T. J., Bursill, C. A., & Hawkins, C. L. (2012). A Novel Role for Myeloperoxidase in the Induction of C/EBP-Homologous Protein (CHOP). Poster session presented at the meeting of FREE RADICAL BIOLOGY AND MEDICINE. San Diego, CA: ELSEVIER SCIENCE INC. DOI |
| Year | Citation |
|---|---|
| 2026 | Beelders, B., Hein, L. K., Wattchow, N., Nguyen, M. T., Torabiardakani, S., Salagaras, T., . . . Psaltis, P. J. (2026). Autophagic flux is increased in peripheral blood mononuclear cells in atherosclerotic vascular disease and associates inversely with adverse cardiovascular events. DOI |
| 2025 | Liu, J., Geremew, D., Sandeman, L. Y., Nankivell, V. A., Chen, R., Xiang, L., . . . Bursill, C. A. (2025). Development of a novel murine model of in-stent neoatherosclerosis. DOI |
| 2025 | Xiang, L., Chen, R., Tan, J., Nankivell, V., Bursill, C. A., McLaughlin, R. A., & Li, J. (2025). Identification and Removal of System-Induced Autofluorescence in Miniaturized Fiber-optic Fluorescence Endoscopes. |
| 2024 | Wong, N. K. P., Solly, E., Le, R., Nankivell, V., Mulangala, J., Psaltis, P., . . . Tan, J. T. M. (2024). TRIM2 Selectively Regulates Inflammation-Driven Pathological Angiogenesis without Affecting Physiological Hypoxia-Mediated Angiogenesis. DOI |
| 2024 | Nankivell, V., Sandeman, L., Stretton, L., Vidanapathirana, A., Rajora, M., Chen, J., . . . Bursill, C. (2024). Multifunctional biomimetic porphyrin-lipid nanoparticles – novel nanoscale theranostics for atherosclerotic cardiovascular disease. DOI |
| 2024 | Ruchka, P., Kushwaha, A., Marathe, J. A., Xiang, L., Chen, R., Kirk, R., . . . Li, J. (2024). 3D-printed axicon enables extended depth-of-focus intravascular optical coherence tomography. |
| 2024 | Primer, K. R., Tan, J. T. M., Sandeman, L., Nankivell, V., Stretton, L. G., Solly, E., . . . Bursill, C. (2024). Reconstituted high-density lipoproteins rescue diabetes-impaired endothelial cell metabolic reprograming and angiogenic responses to hypoxia. DOI |
·National Heart Foundation Lin Huddleston Foundation Fellowship (2017-2022)
Chief Investigator: Christina Bursill (CIA)
Amount: ~$750,000 over 5 years
·Diabetes Australia Research (DART) grant (2017)
Title: ‘Micromanaging’ high-density lipoprotein-induced rescue of diabetes-impaired angiogenesis
Chief Investigators: Joanne Tan and Christina Bursill
Amount: $60,000
· NAB Career Re-start Grant (2016)
Title: Reversing the progression of atherosclerosis
Chief Investigators: Christina Bursill (CIA),
Amount: $60,000 over one year
· ARC Discovery Grant (2016)
Title: Dynamics of atherosclerotic plaque formation, growth and regression
Chief Investigators: Mary Myerscough (CIA), Charlie Macaskill (CIB), Christina Bursill (PI).
Amount: $218,768 over three years
· University of Sydney - Thompson Fellowship (2016)
Title: Using the "Good Cholesterol" to increase stent longevity
Chief Investigator: Christina Bursill (CIA)
Amount: $90, 000 over one year
· University of Sydney Bridging Grant (2015)
Title: Different athero-protective properties of HDL in early versus late atherosclerosis
Chief Investigators: Christina Bursill (CIA)
Amount: $30, 000 over 1 year
· NHMRC Project Grant (2015)
Title: Oxidative Regulation of the Na pump – a new player in vascular function in health and disease.
Chief Investigators: Gemma Figtree (CIA), Christina Bursill (CIB), A/Prof Ravinay Bhindi (CIC), Prof Keith Channon (CID), A/Prof Clare Hawkins (CIE), Dr Ben Davies (CIF), Prof Richard Cohen (CIG).
Amount: $488,816 over three years
· University of Sydney Bridging Grant (2013)
Title: Differential Regulation of Angiogenesis by CC-Chemokines
Chief Investigators: Christina Bursill (CIA)
Amount: $30, 000 over 1 year
· NHMRC project grant (2010-2013)
Title: Multifunctional regulation of Angiogenesis by High Density Lipoproteins
Chief Investigators: Martin Ng (CIA), Christina Bursill (CIB)
Amount: $476, 000 over 3 years
· Heart Foundation Career Development Fellowship (2008-2013)
Title: The Role of Chemokines in the Anti-Atherosclerotic Effects of HDL
Chief Investigator: Christina Bursill
Amount: $515,000 – includes 5 years salary, travel funds and equipment support.
·Bushell Foundation (2008-2011)
Title: Understanding the Anti-Atherosclerotic Properties of High Density Lipoproteins
Investigator: Christina Bursill
Amount: $250, 000 over 3 years
· British Heart Foundation Program Grant (2005-2007):
Title: Evaluation of Broad Spectrum Chemokine agonists to Inhibit Atherosclerosis
Investigators: Keith Channon, David Greaves, and Christina Bursill
Amount: £715,961 over 5 years
· British Heart Foundation Project Grant (2001-2004):
Title: Evaluation of Broad Spectrum CC-Chemokine antagonists to Inhibit Inflammatory Cell Recruitment in Atherogenesis.
Investigators: David Greaves, Keith Channon, and Christina Bursill
Amount: £152,326 over 3 years. Based on the success of the project, the initial grant was extended for a further 2.5 years (£126,939) based on my research.
Undergraduate Teaching:
·1997-98: Tutor for 1st year Medical students in Problem Based Learning, Department of Medicine, University of Adelaide.
·1998-2000: Demonstrator for 2nd year Science students in Cardiovascular Physiology, Department of Physiology, University of Adelaide.
·2001: Lecturer to 2nd year Medical students on Lipoprotein Metabolism, Department of Pathology, University of Oxford, UK.
·2001, 2002: Demonstrator for 2nd year Medical Students in Atherosclerosis and Thrombosis, Department of Pathology, University of Oxford, UK.
·2004-2006: Lecturer to 3rd year Medical students in ‘Methods and Approach in Scientific Research’. Department of Medicine, University of Oxford, UK.
·2015-2026: Lecturer to 3rd year Physiology students on “Vascular Inflammation”, University of Sydney, NSW.
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2026 | Principal Supervisor | Novel atheroprotective properties of diroximel fumarate | Doctor of Philosophy | Doctorate | Full Time | Ms Afreen . |
| 2025 | Co-Supervisor | Mathematical modelling of plaque calcification in atherosclerosis | Master of Philosophy | Master | Full Time | Miss Faith Caren Thando Penn Sawers |
| 2025 | Co-Supervisor | Exploring novel approaches to residual inflammation in coronary artery disease | Doctor of Philosophy | Doctorate | Full Time | Dr Rajesh Pathy |
| 2025 | Co-Supervisor | Mathematical modelling of plaque calcification in atherosclerosis | Doctor of Philosophy | Doctorate | Full Time | Miss Faith Caren Thando Penn Sawers |
| 2024 | Principal Supervisor | Deletion of the asialoglycoprotein receptor 1 (ASGR1) to prevent athersclerotic cardiovascular disease | Doctor of Philosophy | Doctorate | Full Time | Mr Liam George Stretton |
| 2023 | Co-Supervisor | New Predictive Factors that Drive Coronary Artery Disease | Doctor of Philosophy | Doctorate | Full Time | Miss Naomi Elizabeth Wattchow |
| 2023 | Co-Supervisor | The Evaluation and Validation of Autophagy as a Novel Biomarker of Coronary Artery Disease | Doctor of Philosophy | Doctorate | Part Time | Dr Mau Tam Nguyen |
| 2023 | Principal Supervisor | The role of the asialoglycoprotein receptor-1 in immune cell regulation of atherosclerosis | Doctor of Philosophy | Doctorate | Full Time | Mr Demeke Geremew Debebe |
| 2022 | Co-Supervisor | Multimodal imaging probe for atherosclerotic plaque detection | Doctor of Philosophy | Doctorate | Full Time | Miss Rouyan Chen |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2022 - 2026 | Co-Supervisor | Dual-modal Imaging of Atherosclerosis Using Optical Coherence Tomography and Fluorescence | Doctor of Philosophy | Doctorate | Full Time | Miss Rouyan Chen |
| 2019 - 2023 | Principal Supervisor | The Role of Endothelial Cell Metabolic Reprogramming in Diabetes impaired Angiogenesis | Doctor of Philosophy | Doctorate | Full Time | Miss Khalia Rose Primer |
| 2019 - 2023 | Co-Supervisor | MicroRNA-181c-5p - A Novel Therapeutic Target for the Rescue of Diabetes-Impaired Angiogenesis | Doctor of Philosophy | Doctorate | Full Time | Miss Emma Louise Solly |
| 2019 - 2023 | Co-Supervisor | Inhibitory and metabolic effects of diabetes on yolk sac-derived endothelial-macrophage progenitors in postnatal murine tissues | Doctor of Philosophy | Doctorate | Full Time | Ms Sanuri Rashmitha Liyanage |
| 2018 - 2022 | Co-Supervisor | Discovery and characterisation of yolk-sac derived Endothelial-Macrophage progenitor cells in postnatal murine tissues | Doctor of Philosophy | Doctorate | Full Time | Miss Anna Emilie Williamson |
| 2018 - 2022 | Principal Supervisor | The Anti-Inflammatory and Pro-Angiogenic Capacity of High-Density Lipoproteins in Diabetic Wound Healing | Doctor of Philosophy | Doctorate | Full Time | Ms Zahra Lotfollahi |
| 2018 - 2023 | Principal Supervisor | Investigating the theranostic properties of apoA-I-linked porphyrin-lipid nanoparticles in atherosclerosis | Doctor of Philosophy | Doctorate | Full Time | Miss Victoria Ann Nankivell |
| 2018 - 2023 | Principal Supervisor | The role of Asialoglycoprotein Receptor-1 in Atherosclerosis | Doctor of Philosophy | Doctorate | Full Time | Mr Benjamin James Pullen |
| 2017 - 2021 | Co-Supervisor | Vascular Calcification as a Risk Factor for Peripheral Arterial Disease and its Effects on Angiogenesis | Doctor of Philosophy | Doctorate | Full Time | Ms Jocelyne Mulangala |
| Date | Role | Board name | Institution name | Country |
|---|---|---|---|---|
| 2021 - ongoing | Board Member | International Atherosclerosis Society | International Atherosclerosis Society | United States |
| 2020 - 2023 | Treasurer | Australian Cardiovascular Alliance | Australian Cardiovascular Alliance | Australia |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2023 - ongoing | Co-Chair | SA Cardiovascular Research Network | Heart Foundation | Australia |
| 2018 - ongoing | President | Australian Atherosclerosis Society | N/A | Australia |
| Date | Role | Editorial Board Name | Institution | Country |
|---|---|---|---|---|
| 2014 - ongoing | Associate Editor | Journal of Biochemistry | - | - |
| 2013 - ongoing | Associate Editor | PLoS ONE | - | - |